Genzyme Ireland Ltd. Sanofi Winthrop Industrie

The medicinal product is used to prevent and treat transplant rejection, to prevent graft-versus-host disease after hematopoietic cell transplantation in adults, to treat acute and steroid-refractory graft-versus-host disease, and in the treatment of aplastic anemia.

Dosage form: powder for preparation of concentrate for infusion solution

ATC: L04AA04